A Phase I, Open Interaction Study Between Oral Doses of GLPG0634 (200 mg QD) and Single Oral Doses of Midazolam (2 mg) in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Nov 2014
At a glance
- Drugs Filgotinib (Primary) ; Midazolam
- Indications Anxiety disorders; Epilepsy; Insomnia; Rheumatoid arthritis
- Focus Pharmacokinetics
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2013 New source identified and integrated (NCT01798979: ClinicalTrials.gov).
- 24 Feb 2013 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.